Morgan Stanley Has Equal-weight on Hospira
By Gordon Wilcox
November 29, 2011 2:32 PM
November 29, 2011 2:32 PM
Symbols: HSP
Posted in: Analyst Color, News, Reiteration, Intraday Update, Markets, Analyst Ratings, Trading Ideas
Morgan Stanley has an Equal-weight rating on healthcare provider Hospira (NYSE: HSP), according to a note published by the bank today.
“Total IMS sales were up 37% Y/Y vs. September of 48% and August of 55%. Consistent with this, Hospira's base business was roughly flat sequentially and up 7% Y/Y compared to 12% Y/Y in September,” according to the note.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
